Basal metallothionein in tumors: Widespread presence of apoprotein
References (50)
- et al.
Toxicol. Appl. Pharmacol.
(1981) - et al.
Biochem. Biophys. Res. Commun.
(1985) - et al.
FEBS Lett.
(1991) - et al.
Biochem. Biophys. Acta
(1978) J. Biol. Chem.
(1951)Europ. J. Cancer
(1966)- et al.
FEBS Lett.
(1988) - et al.
Cancer Lett.
(1986) - et al.
Toxicology
(1986) - et al.
Toxicol. Appl. Pharmacol.
(1978)
Fr. Rad. Biol. Med.
(1990)
J. Urology
(1991)
Life Sci.
(1986)
Biochem. Biophys. Acta
(1989)
Toxicol. Appl. Pharmacol.
(1979)
J. Biol. Chem.
(1981)
Ann. Rev. Biochem.
(1986)
J. Toxicol. Environ. Health
(1981)
Cancer Chemother. Pharmacol.
(1987)
Cancer Res.
(1983)
Scand. J. Rhumatology
(1985)
Science
(1988)
Cancer Res.
(1988)
Biochem. J.
(1988)
Comm. Inorg. Chem.
(1990)
Cited by (0)
- 1
Department of Biology, Syracuse University, Syracuse, New York. Presently, Visiting Associate, California Institute of Technology, Pasadena, California.
- 2
Parke-Davis Pharmaceutical Research, Division of Warner Lambert Co., Ann Arbor, Michigan.
Copyright © 1994 Published by Elsevier B.V.